Defence Therapeutics's market cap is currently $47.45M. The company's EPS TTM is $-0.192; its P/E ratio is ―; Defence Therapeutics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Income Statement
Total Revenue	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Gross Profit	C$ -90.92K	C$ -13.82K	C$ 0.00	C$ 0.00	C$ 0.00
Operating Income	C$ -12.66M	C$ -6.48M	-	-	C$ -673.18K
EBITDA	C$ -12.68M	C$ -6.48M	C$ 0.00	C$ -2.86M	C$ -673.18K
Net Income	C$ -13.19M	C$ -6.76M	C$ -7.34M	C$ -2.86M	C$ -673.18K
Balance Sheet
Cash & Short-Term Investments	C$ 56.55K	C$ 2.79M	C$ 506.70K	C$ 5.45M	C$ 1.87M
Total Assets	C$ 477.75K	C$ 3.53M	C$ 719.67K	C$ 5.61M	C$ 1.91M
Total Debt	C$ 1.75M	C$ 1.75M	C$ 0.00	C$ 0.00	C$ 0.00
Net Debt	C$ 1.69M	C$ -1.05M	C$ -506.70K	C$ -5.45M	C$ -1.87M
Total Liabilities	C$ 4.06M	C$ 1.97M	C$ 1.11M	C$ 122.26K	C$ 48.35K
Stockholders' Equity	C$ -3.58M	C$ 1.57M	C$ -387.56K	C$ 5.49M	C$ 1.86M
Cash Flow
Free Cash Flow	C$ -4.49M	C$ -7.72M	C$ -6.04M	C$ -2.29M	C$ -178.85K
Operating Cash Flow	C$ -4.29M	C$ -7.66M	C$ -6.04M	C$ -2.29M	C$ -132.83K
Investing Cash Flow	C$ -203.24K	C$ -65.80K	C$ 0.00	C$ 0.00	C$ -46.02K
Financing Cash Flow	C$ 1.76M	C$ 10.01M	C$ 1.10M	C$ 5.88M	C$ 2.04M

Currency in CAD

Defence Therapeutics Earnings and Revenue History

Income Statement >

Defence Therapeutics Debt to Assets

Balance Sheet >

Defence Therapeutics Cash Flow

Cash Flow >

Defence Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing